Last reviewed · How we verify

NCT04884542

Multigen Plus H Study and AMF TT Cones

Recruiting now Last updated 10 March 2025
What this trial tests

trial testing Revision Total Knee Arthroplasty in Arthroplasty, Replacement, Knee in 43 participants. Currently enrolling.

Timeline
19 January 2022
Primary endpoint
30 June 2027
30 June 2027

Quick facts

Lead sponsorLimacorporate S.p.a
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment43
Start date19 January 2022
Primary completion30 June 2027
Estimated completion30 June 2027
Sites2 locations across Belgium, Slovakia

Drugs / interventions tested

Conditions studied

Sponsor

Limacorporate S.p.a

Who can join

18 and older, any sex, with Arthroplasty, Replacement, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the clinical, patient-reported, and radiographic outcomes of a revision Total Knee Arthroplasty with Multigen Plus H and AMF TT Cones.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthroplasty, Replacement, Knee

Currently open trials in the same condition.

Other Limacorporate S.p.a trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04884542.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing